Almutairdi A
ORCID: 0009-0008-7000-2905
· 1 paper in corpus
2018
Vedolizumab and early postoperative complications in nonintestinal surgery: a case-matched analysis.
BackgroundVedolizumab (VDZ) is a gut-specific α4-β7 integrin antagonist that has demonstrated efficacy in Crohn's disease (CD) and ulcerative colitis (UC). The safety of VDZ in the perioperative period remains unclear. The aim of this study…